Beta adrenoceptor mediation of the enhancing effect of norepinephrine on the murine primary antibody response in vitro.
The beta adrenoceptor has been identified in this study to be the receptor responsible for the enhanced immunoglobulin M antibody response produced by norepinephrine in mouse spleen cells immunized with sheep erythrocytes in vitro. The magnitude and kinetics of the enhanced antibody response to norepinephrine alone, or to norepinephrine in the presence of phentolamine, were more closely mimicked with a beta-2 adrenoceptor agonist (terbutaline) than with a beta-1 adrenoceptor agonist (dobutamine). Norepinephrine alone, norepinephrine in the presence of phentolamine, or terbutaline exposure produced a number of spleen cells secreting immunoglobulin M antibody that is equal to control on day 4 after immunization and which is enhanced above control on days 5, 6 and 7. Dobutamine causes no change when compared to control on days 4 and 5, but causes a delayed decline in the response on days 6 and 7. All drug responses were concentration-dependent and propranolol antagonized the enhanced response observed in the presence of terbutaline or dobutamine alone. When norepinephrine was added to immunized spleen cell cultures in the presence of propranolol, an alpha adrenoceptor-mediated component was unmasked which produced an enhanced response on day 4 after immunization and returned to control levels on days 5, 6 and 7. These results suggest that antibody responses can be modulated positively by a sympathetic neurotransmitter. This up-modulation by norepinephrine is beta adrenoceptor-mediated at the time of, and after, peak control response and alpha adrenoceptor-mediated 1 day before peak control response.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D004280:Dobutamine / Q000494:pharmacology; D005260:Female; D066298:In Vitro Techniques; D007545:Isoproterenol / Q000494:pharmacology; D007700:Kinetics; D051379:Mice; D008810:Mice, Inbred C57BL; D009638:Norepinephrine / Q000494:pharmacology*; D010646:Phentolamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011943:Receptors, Adrenergic, beta / Q000378:metabolism*; D013726:Terbutaline / Q000494:pharmacology
D011943:Receptors, Adrenergic, beta; D004280:Dobutamine; D011433:Propranolol; D007545:Isoproterenol; D013726:Terbutaline; D009638:Norepinephrine; D010646:Phentolamine